| Today's Open | $12.38 |
|---|---|
| Previous Close | $12.36 |
| Daily Range | $12.36 - $12.55 |
| 52-Week Range | $9.37 - $14.91 |
| Market Cap | $7.5B |
| P/E Ratio | -19.62 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 19,008,470 |
| Average Daily Volume | 8,707,071 |
| Current FY EPS | $0.19 |
Sector
Healthcare
Industry
Drugs
Elan (ELN) Description
The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Website: http://www.elan.com/
News & Commentary
Elan Board Rejects Royalty Pharma's Latest Offer
The Ireland-based biotech firm's board unanimously declines the latest buyout offer.ELN's Top Competitors
(0.89%)
(0.73%)
(-0.24%)
(-0.45%)